Sadigh, Gelareh http://orcid.org/0000-0003-3233-1878
Switchenko, Jeffrey
Weaver, Kathryn E.
Elchoufi, Deema
Meisel, Jane
Bilen, Mehmet Asim
Lawson, David
Cella, David
El-Rayes, Bassel
Carlos, Ruth
Funding for this research was provided by:
Association of University Radiologists
Article History
Received: 9 February 2021
Accepted: 8 July 2021
First Online: 13 July 2021
Declarations
:
: The study was approved by Emory University Institutional Review Board (IRB approval # IRB00108258) and was Health Insurance Portability and Accountability Act (HIPAA) compliant.
: Written informed consent was obtained from all participants.
: Patients signed informed consent regarding publishing their data.
: Dr. Sadigh received salary support from AUR GERRAF. Dr. Carlos receives salary support from theĀ <i>Journal of the American College of Radiology</i> and research support from the Neiman Health Policy Institute. Dr. Bilen has acted as a paid consultant for and/or as a member of the advisory boards of Exelixis, Bayer, BMS, Eisai, Pfizer, AstraZeneca, Janssen, Genomic Health, Nektar, and Sanofi and has received grants to his institution from Xencor, Bayer, Bristol-Myers Squibb, Genentech/Roche, Seattle Genetics, Incyte, Nektar, AstraZeneca, Tricon Pharmaceuticals, Peleton Therapeutics, and Pfizer for work performed as outside of the current study. Dr. Meisel has acted as a member of the advisory boards of Pfizer and Puma and has received grants to her institution from Pfizer, Seattle Genetics, and Eli Lilly. Dr. Cella is the president of FACIT.ORG. Drs. Switchenko, Elchoufi, Lawson, Weaver, and El-Rayes do not report any conflict of interests.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, National Cancer Institute or ECOG-ACRIN.